Back
Opus Genetics, Inc. IRD · Insights
Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The comp... Price4.2
Market Cap349.44 M
Float80.41 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro